Tag Archives: Pfizer

The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday. Pfizer said it expected the drug, marketed under the name Zavzpret, to be available in pharmacies in July 2023. “The FDA approval of Zavzpret marks a …

The US researchers have created a vaccine based on the same mRNA technology used in the Covid-19 jabs from Moderna and Pfizer. A universal flu vaccine that can protect against all strains of the virus could be available in the next two years, a leading expert has said. Professor John …

The European Commission said that between 60% and 80% of the EU population was estimated to have been infected with COVID-19, as the bloc enters a post-emergency phase in which mass reporting of cases was no longer necessary. In preparing for this less acute phase, European Union governments should ramp …

U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer. That pill is likely to become the first-choice treatment …

The new Pfizer COVID-19 pill may not see Emergency Use Authorization for another month as health officials continue to highlight the promising effects it may bring. Dr. Anthony Fauci praised the data presented by Pfizer regarding the COVID pill, which someone would take within 48 hours of showing symptoms and …

Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89 percent among high-risk adults when taken shortly …

The Food and Drug Administration opened booster shots for the Pfizer / BioNTech and Moderna COVID-19 vaccine to all adults today, the companies announced, expanding eligibility outside of the initial, vulnerable groups they were cleared for earlier this fall. Although the COVID-19 vaccines available in the United States are still …

Pfizer Inc said on Thursday it had signed a $5.29 billion deal with the US government to deliver 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes to secure promising oral treatments for the disease. The deal is rough twice the size of the contract the …

The Iraqi Ministry of Health authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 12 through 18 years of age. An official document issued by the Ministry on Monday said that the authorization was based on the recommendations of advisory committee experts …

The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday. Sixteen children in the trial who had received a placebo got COVID-19, compared with 3 who were vaccinated, Pfizer said in briefing documents …

The US Food and Drug Administration is expected to soon recommend that persons 40 and older receive Pfizer or Moderna COVID-19 booster shots, CNN reported on Tuesday. The US has administered 409,438,987 doses of COVID-19 vaccines in the country as of Tuesday morning and distributed 495,844,635 doses, the US Centers …

The Pfizer Inc/BioNTech SE COVID-19 vaccine was 93 percent effective in preventing hospitalizations among those aged 12 to 18, according to an analysis released by the US Centers for Disease Control and Prevention (CDC) on Tuesday. The study was conducted between June and September when the extremely contagious Delta variant …

The Border Ports Authority announced the arrival of a new batch of Pfizer vaccines. The Border Ports Authority said in a statement received by AlghadeerTv, that “in according to the directives of the Supreme Committee for Health and National Safety, the authority continues supporting for the health reality to confront …

Sweden’s Public Health Agency on Wednesday recommended a temporary halt to the use of the Moderna Covid-19 vaccine among young adults, citing concerns over rare side effects to the heart. It said the pause should initially be in force until December 1, explaining that it had received evidence of an …

Positive clinical trial results for Merck & Co’s (MRK.N) experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker’s stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Merck shares jumped as much as 12.3% and hit their highest …

US health officials are preparing to consider more COVID-19 vaccine boosters for adults and the first vaccine shots for children younger than 12. The Food and Drug Administration said its panel of outside vaccine experts will meet Oct. 14 and 15 to consider whether to recommend booster doses for adults …

Iraq received about a million new batches of Covid-19 vaccines. A source told Shafaq News Agency that the Iraqi Company for marketing drugs and medical appliances, affiliated with the Ministry of Health and Environment, has received new batches of vaccines, medicines, and protocols for protecting and treating the past ten …

German company BioNTech, which in partnership with Pfizer developed one of the most widely used anti-Covid shots, says it’s preparing for the worldwide launch of its jab for younger recipients and might get approval in October. An mRNA vaccine against coronavirus for children aged between five and 11 years old …

South Africa’s health regulator has approved Pfizer’s COVID-19 vaccine for use by children aged 12 and older, paving the way for the government to offer vaccinations to teenagers. The South African Health Products Authority (SAPHRA) said the decision came after a review of updated safety and efficacy information submitted in …

Fully vaccinated people were 11 times less likely to die of COVID-19 and 10 times less likely to be hospitalized since highly contagious Delta became the most common variant, US health authorities said Friday. The data came from one of three new papers published by the Centers for Disease Control …